NA
QTTB icon

Neuburgh Advisers’s Q32 Bio QTTB Stock Holding History

Neuburgh Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$25K Buy
+78
New +$26.5K ﹤0.01% 875

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuburgh Advisers's QTTB Position: Q3 2019 in Review

Neuburgh Advisers opened a new position in Q32 Bio (QTTB) in Q3 2019: 78 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #875 among its holdings.

80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • Neuburgh Advisers held 78 shares of Q32 Bio worth $25K as of Q3 2019.
  • Q32 Bio was a new Neuburgh Advisers position in Q3 2019.
  • Q32 Bio made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #875 holding.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.